WO1999058699A3 - Facteurs de coagulation du sang humain derives de plantes transgeniques - Google Patents
Facteurs de coagulation du sang humain derives de plantes transgeniques Download PDFInfo
- Publication number
- WO1999058699A3 WO1999058699A3 PCT/US1999/010732 US9910732W WO9958699A3 WO 1999058699 A3 WO1999058699 A3 WO 1999058699A3 US 9910732 W US9910732 W US 9910732W WO 9958699 A3 WO9958699 A3 WO 9958699A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coagulation factors
- plant
- transgenic plant
- human blood
- derived human
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/644—Coagulation factor IXa (3.4.21.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6429—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21005—Thrombin (3.4.21.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21022—Coagulation factor IXa (3.4.21.22)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99921969A EP1076698A2 (fr) | 1998-05-14 | 1999-05-14 | Facteurs de coagulation du sang humain derives de plantes transgeniques |
JP2000548490A JP2002514433A (ja) | 1998-05-14 | 1999-05-14 | トランスジェニック植物由来ヒト凝血因子 |
CA002328493A CA2328493A1 (fr) | 1998-05-14 | 1999-05-14 | Facteurs de coagulation du sang humain derives de plantes transgeniques |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8000398A | 1998-05-14 | 1998-05-14 | |
US09/080,003 | 1998-05-14 | ||
US30684799A | 1999-05-06 | 1999-05-06 | |
US09/306,847 | 1999-05-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999058699A2 WO1999058699A2 (fr) | 1999-11-18 |
WO1999058699A3 true WO1999058699A3 (fr) | 2000-04-06 |
Family
ID=26762686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/010732 WO1999058699A2 (fr) | 1998-05-14 | 1999-05-14 | Facteurs de coagulation du sang humain derives de plantes transgeniques |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1076698A2 (fr) |
JP (1) | JP2002514433A (fr) |
CA (1) | CA2328493A1 (fr) |
WO (1) | WO1999058699A2 (fr) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1282439B1 (fr) * | 2000-05-10 | 2005-11-30 | Novo Nordisk Health Care AG | COMPOSITION PHARMACEUTIQUE COMPRENANT UN FACTEUR VIIa ET UN INHIBITEUR DE TFPI |
ES2640613T3 (es) * | 2000-07-21 | 2017-11-03 | Revance Therapeutics, Inc. | Sistemas de transporte de agentes biológicos de múltiples componentes |
ATE423199T1 (de) * | 2001-07-06 | 2009-03-15 | Chemo Sero Therapeut Res Inst | Verfahren zur herstelllung von menschlichem thrombin mittels genmodifikationstechnik |
CZ2004543A3 (cs) * | 2001-11-09 | 2004-08-18 | Novoánordiskáa@S | Farmaceutický prostředek obsahující polypeptidy faktoru VII a polypeptidy faktoru V |
US7125846B2 (en) | 2001-11-09 | 2006-10-24 | Novo Nordisk Healthcare A/G | Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides |
WO2005123928A1 (fr) * | 2004-06-08 | 2005-12-29 | Battelle Memorial Institute | Production du facteur viii de coagulation humain à partir de cellules végétales et de plantes entières |
WO2006004675A2 (fr) | 2004-06-25 | 2006-01-12 | Altor Bioscience Corporation | Production d'un facteur tissulaire chez des plantes |
CA3217359A1 (fr) * | 2022-10-18 | 2024-04-18 | Proview-Mbd Biotech Co., Ltd. | Production d'alpha-thrombine humaine recombinante dans un systeme a base de plante et application connexe |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0268772A2 (fr) * | 1986-09-19 | 1988-06-01 | ZymoGenetics, Inc. | Expression du facteur XIII biologiquement actif |
WO1991002066A1 (fr) * | 1989-07-26 | 1991-02-21 | Mogen International N.V. | Production de proteines heterologues dans les vegetaux et cellules vegetales |
WO1993013208A1 (fr) * | 1991-12-31 | 1993-07-08 | Zymogenetics, Inc. | Procedes de production de thrombine |
WO1994017415A1 (fr) * | 1993-01-29 | 1994-08-04 | Dahlbaeck Bjoern | Nouvelle activite de cofacteur anticoagulant |
US5723755A (en) * | 1995-05-16 | 1998-03-03 | Francis E. Lefaivre | Large scale production of human or animal proteins using plant bioreactors |
-
1999
- 1999-05-14 WO PCT/US1999/010732 patent/WO1999058699A2/fr not_active Application Discontinuation
- 1999-05-14 JP JP2000548490A patent/JP2002514433A/ja active Pending
- 1999-05-14 EP EP99921969A patent/EP1076698A2/fr not_active Withdrawn
- 1999-05-14 CA CA002328493A patent/CA2328493A1/fr not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0268772A2 (fr) * | 1986-09-19 | 1988-06-01 | ZymoGenetics, Inc. | Expression du facteur XIII biologiquement actif |
WO1991002066A1 (fr) * | 1989-07-26 | 1991-02-21 | Mogen International N.V. | Production de proteines heterologues dans les vegetaux et cellules vegetales |
WO1993013208A1 (fr) * | 1991-12-31 | 1993-07-08 | Zymogenetics, Inc. | Procedes de production de thrombine |
WO1994017415A1 (fr) * | 1993-01-29 | 1994-08-04 | Dahlbaeck Bjoern | Nouvelle activite de cofacteur anticoagulant |
US5723755A (en) * | 1995-05-16 | 1998-03-03 | Francis E. Lefaivre | Large scale production of human or animal proteins using plant bioreactors |
Non-Patent Citations (3)
Title |
---|
CRAMER C L ET AL: "Bioproduction of human enzymes in transgenic tobacco.", ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, (1996 MAY 25) 792 62-71. REF 50, XP000856387 * |
DAI Z Y (REPRINT) ET AL: "Expression of human coagulation factor VIII gene in tobacco.", PLANT PHYSIOLOGY, (JUL 1997) VOL. 114, NO. 3, SUPP. [S], PP. 1584-1584. PUBLISHER: AMER SOC PLANT PHYSIOLOGISTS, 15501 MONONA DRIVE, ROCKVILLE, M 20855. ISSN: 0032-0889., BATTELLE MEM INST, PACIFIC NW LABS, BIOPROC GRP, RICHLAND, WA 99352, XP002123654 * |
KANE W H ET AL: "Expression and characterization of recombinant human factor V and a mutant lacking a major portion of the connecting region.", BIOCHEMISTRY, (1990 JUL 24) 29 (29) 6762-8., XP002123653 * |
Also Published As
Publication number | Publication date |
---|---|
JP2002514433A (ja) | 2002-05-21 |
EP1076698A2 (fr) | 2001-02-21 |
CA2328493A1 (fr) | 1999-11-18 |
WO1999058699A2 (fr) | 1999-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2266499A3 (fr) | Structure tridimensionnelle de tissus | |
WO2000009725A3 (fr) | Procede d'extraction de proteines du fluide interstitiel de tissus vegetaux | |
AR004938A1 (es) | Proteina derivada de alfa-hordotionina de alto contenido en metionina, secuencias de nucleotidos, arn y adn, cassete de expresion, vector detransformacion bacteriana, celulas bacterianas y vegetales transformadas, celula o cultivo de tejidos de maiz y metodo para potenciar el contenido de | |
WO1998045456A8 (fr) | Sequences d'adn codant pour une 2-desoxyglucose-6-phosphate (2-dog-6-p) phosphatase et servant de marqueur de selection chez les vegetaux | |
ATE526818T1 (de) | Gentechnisch hergestellte wasserlinse | |
EP2169069A3 (fr) | Protéines de phosphatase liées au stress et procédés d'utilisation dans des plantes | |
ATE517185T1 (de) | Methoden zur herstellung von pflanzen mit erhöhtem ölsäuregehalt | |
BR0015148A (pt) | Produção androgenética ou ginogenética de linhas de células e células pluripotentes, e seu uso para produzir tecidos e células diferenciados | |
IE881323L (en) | Plant tissue transformation | |
WO2001045492A3 (fr) | Proteines de proteine kinase liees au stress et procedes d'utilisation dans les plantes | |
SG2013021217A (en) | Production of high mannose proteins in plant culture | |
NO20053357L (no) | Dyrkingsmedium, dyrkingsmetode og de oppnadde myoblaster og deres anvendelse. | |
WO2004022696A3 (fr) | Supports de cellules de fibrine et procedes pour les utiliser | |
SE8800157D0 (sv) | Transformation and foreign gene expression in brassica species | |
WO1999058699A3 (fr) | Facteurs de coagulation du sang humain derives de plantes transgeniques | |
DE60014635D1 (de) | Verfahren zur expression und isolierung von rekombinanten proteinen und rekombinanten proteinprodukten von pflanzen, pflanzlichen geweben oder kultivierten pflanzenzellen | |
WO2000056905A3 (fr) | Procede pour accelerer et/ou ameliorer la croissance et/ou le rendement de vegetaux ou pour modifier leur architecture | |
EP0249432A3 (fr) | Transformation et expression de gènes étrangers avec des espèces végétales | |
WO2001029240A3 (fr) | Regeneration | |
WO2000078927A3 (fr) | Preparation spheroide | |
CA2275974A1 (fr) | Procedes permettant de produire des plantes transgeniques femelles steriles | |
EP0945073A3 (fr) | Procédé de production d'un arôme ou parfum naturel | |
CN104911142B (zh) | 一种鹿真皮毛乳头细胞的体外分离培养方法及应用 | |
WO1999013083A3 (fr) | Methode et dispositif de modulation de proteines de cycle cellulaire vegetal et leur utilisation dans la regulation de la croissance de cellules vegetales | |
ES2132027A1 (es) | Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2328493 Country of ref document: CA Ref country code: CA Ref document number: 2328493 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 548490 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999921969 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999921969 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999921969 Country of ref document: EP |